Acute Interstitial Pneumonia Clinical Trials

Find Acute Interstitial Pneumonia Clinical Trials Near You

Functional Magnetic Resonance Imaging of the Lung to Detect Regional Reversibility and Progression in Interstitial Lung Disease

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The main objective of this study is to investigate the utility of functional MRI to differentiate, characterize, and monitor subgroups of ILD. This can be broken down into three specific objectives: Determine if ILD features observed on high-resolution computed tomography (HRCT), such as ground glass opacities (GGO), are functionally different. Analyse MRI metrics within each subgroup to determine whether these metrics distinguish different ILDs. Assess MRI metrics longitudinally to see if these parameters change with disease progression, stability, or reversibility.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Clinical indication for a routine HRCT because of either newly diagnosed idiopathic pulmonary fibrosis (IPF) or hypersensitivity pneumonitis (HP) or idiopathic non-specific interstitial pneumonia (iNSIP), suspected diagnosis, or follow-up

• Capacity to consent

• Ability to participate fully in the study (defined by the ability to lie still for the duration of imaging)

Locations
Other Locations
Germany
Thoraxklink Heidelberg - Universitätsklinikum Heidelberg
RECRUITING
Heidelberg
Universitätsklinikum Schleswig-Holstein, Campus Kiel
ACTIVE_NOT_RECRUITING
Kiel
Time Frame
Start Date: 2025-11-20
Estimated Completion Date: 2027-07
Participants
Target number of participants: 200
Treatments
Experimental: MRI Examination Protocol
Sponsors
Collaborators: University Hospital Schleswig-Holstein, German Center for Lung Research, Thoraxklinik-Heidelberg gGmbH
Leads: University Hospital Heidelberg

This content was sourced from clinicaltrials.gov